This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Council of Scientific and Industrial Research. Active years: 2001-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Uttar Pradesh, IN (2002)
- Lucknow, IN (2001 - 2005)
Company Filing History:
Years Active: 2001-2005
Title: Innovations of Wahajul Haq
Introduction
Wahajul Haq is a notable inventor based in Lucknow, India. He has made significant contributions to the field of biotechnology, particularly in the development of novel peptides and pharmaceutical compositions. With a total of 4 patents, his work has the potential to impact medical diagnostics and treatment.
Latest Patents
Wahajul Haq's latest patents include innovative solutions for medical applications. One of his notable inventions is related to polypeptides useful for the diagnosis of Aspergillus fumigatus. This invention focuses on novel peptide sequences derived from the immunodominant region of an 18 kD major allergen, which can enhance diagnostic accuracy. Another significant patent involves the creation of inclusion complexes of a highly potent opioid peptide with cyclodextrin. This invention aims to improve the solubility and biopharmaceutical properties of the peptide, offering better analgesic action and reduced toxicity.
Career Highlights
Wahajul Haq is affiliated with the Council of Scientific and Industrial Research, where he conducts research and development in biotechnology. His work has garnered attention for its innovative approach to solving complex medical challenges.
Collaborations
Wahajul has collaborated with esteemed colleagues such as Puranam U Sarma and Taruna Madan, contributing to a dynamic research environment that fosters innovation.
Conclusion
Wahajul Haq's contributions to biotechnology through his patents reflect his commitment to advancing medical science. His innovative work continues to pave the way for new diagnostic and therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
